What did @golfmusclemaster actually say?
The creator walked through a subcutaneous injection protocol for GHK-Cu (copper tripeptide), covering vial prep, air-displacement drawing, bubble removal, warming the solution to room temperature, injection angle based on body composition, and slow plunger technique. They also recommended topical Benadryl cream or ice for post-injection stinging, attributing that stinging specifically to the copper component of GHK-Cu.
The video is framed as education for people already using peptides who are experiencing lumps, discomfort, or stinging. The creator demonstrates on themselves, noting they're injecting "four units" of a "high concentration" GHK-Cu solution and recommending a 90-degree angle because they have enough subcutaneous fat to support it. They also suggest leaving the filled syringe at room temperature for roughly 15 minutes before injecting.
Does the science back this up?
Most of the injection mechanics described here are consistent with established subcutaneous injection technique. The science isn't controversial on the basics. Where things get murkier is the specific claim about copper causing stinging and the recommendation to use a topical antihistamine as the fix.
The air-displacement method the creator describes, drawing air equal to your desired volume before inserting the needle, is a legitimate technique used to create positive pressure and reduce bubble formation. This is consistent with standard vial-drawing protocols taught in clinical settings. Warming a solution to body or room temperature before injection is also supported: cold solutions injected subcutaneously have been shown to cause more discomfort and slower absorption. A 2019 review in Diabetes Technology and Therapeutics (Gentile et al.) confirmed that room-temperature insulin produced less injection-site pain than refrigerated insulin, which is a reasonable analogy here. The 45-versus-90-degree angle guidance based on subcutaneous fat depth is textbook nursing instruction, not invented advice.
What did they get right and wrong?
Credit where it's due: the core injection mechanics, wiping the vial with alcohol, displacing air, tapping bubbles to the top, warming the solution, slow insertion and slow plunger depression, are genuinely good practice. These aren't bro-science tips. They reflect real clinical guidance for minimizing injection-site trauma.
The stinging attribution is shakier. The creator says "the copper can sometimes elicit some pain or stinging" and recommends topical diphenhydramine (Benadryl cream) as a fix. There is some basis for copper peptides causing localized irritation, GHK-Cu has been studied for skin applications and does have known mild irritant potential at higher concentrations (Pickart and Margolina, 2018, Biomolecules). But characterizing stinging as primarily a copper-mediated histamine response that warrants a topical antihistamine is a stretch. Injection-site stinging is more often caused by pH, osmolarity, concentration, or injection speed than by a specific ion. The Benadryl recommendation isn't dangerous, but it's not evidence-based for this specific application either.
The creator also never mentions that GHK-Cu is not FDA-approved for injectable use and that injection-grade preparation quality varies significantly across suppliers. That omission matters.
What should you actually know?
If you are injecting any peptide subcutaneously, the mechanical technique this video covers is a reasonable starting point. Slow injection speed, room-temperature solution, appropriate angle for your fat layer, and clean prep all reduce discomfort and improve tolerability. These principles apply broadly.
What the video doesn't address is sterility beyond surface swabbing, reconstitution technique, bacteriostatic versus sterile water, storage conditions, or what to do if a lump doesn't resolve. Persistent lumps, redness, warmth, or swelling at an injection site can indicate lipodystrophy or infection, not just technique error, and those require medical evaluation, not just a slower plunger. GHK-Cu is also not a regulated therapeutic in injectable form in the United States. Anyone using it is operating outside clinical oversight, which means supplier quality, concentration accuracy, and sterility are entirely unverified. A topical antihistamine is not a substitute for knowing what's actually in your vial.
The regulatory picture you can't ignore
GHK-Cu in injectable form is not FDA-approved. The creator does not mention this, and 23,000 viewers watching a step-by-step injection tutorial deserve that disclosure. Compounded peptide preparations exist in a legal gray zone. The FDA has taken enforcement action against compounders supplying unapproved peptides, and the quality of products sourced outside of licensed compounding pharmacies is completely uncontrolled. The injection technique shown may be sound, but injecting an unverified compound using that technique does not make the practice safe. Technique and product quality are separate variables, and this video only addresses one of them.